OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.
Grand River Aseptic Manufacturing, Inc. (GRAM) announced on March 6, 2018 the addition of syringe filling capabilities at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, MI. A Colanar FSV syringe filler, which can also handle cartridges, will use the existing single-use systems for small-molecule APIs and biologics projects. The equipment will be qualified and operational by the second quarter of 2018.
The capital investments were made following the announcement of a partnership deal with Arlington Capital Partners, a private equity firm. “With the support of Arlington, GRAM intends to invest heavily in building out our capabilities in the next couple of years with state-of-the-art equipment and a new facility. The new syringe filler is the first of many exciting announcements we will be making this year,” said Tom Ross, president and CEO of GRAM, in a press release.